Trgovina Bonus BioGroup Ltd. - BBIXF CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Razmik | - | ||||||||
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.024068% | ||||||||
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.001846% | ||||||||
Čas nočne pristojbine | 21:00 (UTC) | ||||||||
Min. tržena količina | 1 | ||||||||
Valuta | USD | ||||||||
Kritje | 20% | ||||||||
Borza | United States of America | ||||||||
Provizija na trgovanje | 0% |
*Information provided by Capital.com
Predhodno. Zapri* | N/A |
Odpri* | N/A |
Enoletna sprememba* | N/A |
Dnevni razpon* | N/A |
Razpon 52 wk | 0.21-1.44 |
Povprečni obseg (10 dni) | 2.51M |
Povprečni obseg (3 meseci) | 105.72M |
Tržna kapitalizacija | 249.94M |
Razmerje P/E | -100.00K |
Število delnic v obtoku | 1.17B |
Prihodki | N/A |
EPS | -0.03 |
Dividenda (donosnost v %) | N/A |
Beta | 2.10 |
Datum naslednjega zaslužka | N/A |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
---|
Bonus BioGroup Ltd. Events
Čas (UTC) (UTC) | Država | Dogodek |
---|---|---|
No events scheduled |
- Letni
- Četrtletno
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Skupni prihodki | 0 | 0 | 0 | 0 | 0 | 0 |
Prihodki | 0 | 0 | 0 | |||
Celotni odhodki iz poslovanja | 15.963 | 20.13 | 18.45 | 20.909 | 19.444 | 64.735 |
Celotna prodaja/splošni/upravni stroški Odhodki | 9.059 | 9.201 | 7.567 | 9.752 | 8.023 | 43.75 |
Raziskave in razvoj | 6.904 | 10.767 | 10.686 | 10.08 | 10.354 | 19.509 |
Other Operating Expenses, Total | 0 | |||||
Prihodki iz poslovanja | -15.963 | -20.13 | -18.45 | -20.909 | -19.444 | -64.735 |
Drugo, neto | -0.083 | -0.067 | -0.364 | -0.195 | -1.408 | -24.936 |
Čisti dobiček pred obdavčitvijo | -16.046 | -20.197 | -18.735 | -22.24 | -22.021 | -90.076 |
Čisti dobiček po davkih | -16.046 | -20.197 | -18.735 | -22.24 | -22.021 | -90.076 |
Čisti dobiček pred dodatnimi postavkami | -16.046 | -20.197 | -18.735 | -22.24 | -22.021 | -90.076 |
Čisti dobiček | -16.046 | -20.197 | -18.735 | -22.24 | -22.021 | -90.076 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -16.046 | -20.197 | -18.735 | -22.24 | -22.021 | -90.076 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -16.046 | -20.197 | -18.735 | -22.24 | -22.021 | -90.076 |
Popravljen čisti dobiček | -16.046 | -20.197 | -18.735 | -22.24 | -22.021 | -90.076 |
Popravljene ponderirane povprečne delnice | 233.543 | 808.995 | 811.497 | 841.467 | 998.981 | 1154.06 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.06871 | -0.02497 | -0.02309 | -0.02643 | -0.02204 | -0.07805 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | 0 | |
Popravljen normalizirani dobiček na enoto čistega dobička | -0.06871 | -0.02497 | -0.02309 | -0.02643 | -0.02204 | -0.07805 |
Depreciation / Amortization | 0.162 | 0.197 | 1.077 | 1.067 | 1.476 | |
Prihodki (odhodki) od obresti, neto Neoperativni | 0.079 | -1.136 | -1.169 | -0.405 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Skupni prihodki | 0 | 0 | 0 | 0 | 0 |
Celotni odhodki iz poslovanja | 36.762 | 8.027 | 10.375 | 9.571 | 9.579 |
Celotna prodaja/splošni/upravni stroški Odhodki | 31.548 | 4.643 | 3.635 | 4.117 | 3.645 |
Raziskave in razvoj | 5.214 | 3.384 | 6.74 | 5.454 | 5.934 |
Prihodki iz poslovanja | -36.762 | -8.027 | -10.375 | -9.571 | -9.579 |
Prihodki (odhodki) od obresti, neto Neoperativni | 1.204 | 0 | -0.005 | -0.463 | 2.506 |
Drugo, neto | -9.4 | -9.556 | -1.148 | -5.973 | -0.231 |
Čisti dobiček pred obdavčitvijo | -44.958 | -17.583 | -11.528 | -16.007 | -7.304 |
Čisti dobiček po davkih | -44.958 | -17.583 | -11.528 | -16.007 | -7.304 |
Čisti dobiček pred dodatnimi postavkami | -44.958 | -17.583 | -11.528 | -16.007 | -7.304 |
Čisti dobiček | -44.958 | -17.583 | -11.528 | -16.007 | -7.304 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -44.958 | -17.583 | -11.528 | -16.007 | -7.304 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -44.958 | -17.583 | -11.528 | -16.007 | -7.304 |
Popravljen čisti dobiček | -44.958 | -17.583 | -11.528 | -16.007 | -7.304 |
Popravljene ponderirane povprečne delnice | 1067.15 | 1069.13 | 1153.42 | 1155.96 | 1167.93 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.04213 | -0.01645 | -0.00999 | -0.01385 | -0.00625 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Popravljen normalizirani dobiček na enoto čistega dobička | -0.04213 | -0.01645 | -0.00999 | -0.01385 | -0.00625 |
- Letni
- Četrtletno
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 2.076 | 4.651 | 9.088 | 0.308 | 16.737 | 81.001 |
Denarna sredstva in kratkoročne naložbe | 1.401 | 2.725 | 8.641 | 0.105 | 16.086 | 79.55 |
Denarna sredstva in ustrezniki | 1.401 | 2.725 | 8.641 | 0.105 | 16.086 | 79.55 |
Celotne terjatve, neto | 0.675 | 1.88 | 0.424 | 0.102 | 0.41 | 1.155 |
Accounts Receivable - Trade, Net | 0.675 | |||||
Other Current Assets, Total | 0 | |||||
Total Assets | 2.896 | 5.577 | 10.158 | 6.99 | 51.437 | 104.322 |
Property/Plant/Equipment, Total - Net | 0.717 | 0.824 | 0.973 | 6.585 | 5.726 | 14.961 |
Intangibles, Net | 0.006 | 0.005 | ||||
Other Long Term Assets, Total | 0.097 | 0.097 | 0.097 | 0.097 | 0.097 | 0.464 |
Total Current Liabilities | 10.259 | 11.961 | 12.45 | 15.545 | 16.374 | 8.771 |
Accounts Payable | 1.355 | 1.047 | 1.221 | 1.48 | 1.559 | 3.994 |
Payable/Accrued | 3.671 | |||||
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 5.233 | 7.273 | 8.275 | 9.362 | 11.185 | 1.118 |
Total Liabilities | 10.259 | 11.961 | 13.335 | 20.711 | 20.753 | 19.892 |
Total Long Term Debt | 0 | 0 | 0 | 5.166 | 4.379 | 11.121 |
Total Equity | -7.363 | -6.384 | -3.177 | -13.721 | 30.684 | 84.43 |
Common Stock | 50.105 | 65.133 | 68.757 | 85.011 | 156.654 | 296.524 |
Retained Earnings (Accumulated Deficit) | -58.199 | -71.517 | -87.731 | -105.346 | -125.97 | -212.094 |
Other Equity, Total | 0.731 | 0 | 15.797 | 6.614 | 0 | |
Total Liabilities & Shareholders’ Equity | 2.896 | 5.577 | 10.158 | 6.99 | 51.437 | 104.322 |
Total Common Shares Outstanding | 241.611 | 808.995 | 811.497 | 841.467 | 998.981 | 1154.06 |
Prepaid Expenses | 0.046 | 0.023 | 0.101 | 0.241 | 0.296 | |
Property/Plant/Equipment, Total - Gross | 2.538 | 2.886 | 9.575 | 9.762 | 20.455 | |
Accumulated Depreciation, Total | -1.714 | -1.913 | -2.99 | -4.036 | -5.494 | |
Accrued Expenses | 3.641 | 2.954 | 3.993 | 2.855 | 2.43 | |
Other Liabilities, Total | 0.885 | |||||
Long Term Investments | 0 | 28.877 | 7.896 | |||
Current Port. of LT Debt/Capital Leases | 0.71 | 0.775 | 1.229 | |||
Capital Lease Obligations | 5.166 | 4.379 | 11.121 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 92.77 | 82.69 | 92.565 | 81.001 | 78.283 |
Denarna sredstva in kratkoročne naložbe | 88.778 | 81.257 | 91.467 | 79.55 | 71.95 |
Denarna sredstva in ustrezniki | 88.778 | 81.257 | 91.467 | 79.55 | 71.95 |
Celotne terjatve, neto | 3.992 | 1.433 | 1.098 | 1.451 | 6.333 |
Accounts Receivable - Trade, Net | 3.992 | 1.433 | 1.098 | 1.451 | 6.333 |
Total Assets | 118.308 | 96.567 | 117.112 | 104.322 | 105.758 |
Property/Plant/Equipment, Total - Net | 5.87 | 1.752 | 12.649 | 14.961 | 18.518 |
Long Term Investments | 19.571 | 11.661 | 11.434 | 7.896 | 8.493 |
Other Long Term Assets, Total | 0.097 | 0.464 | 0.464 | 0.464 | 0.464 |
Total Current Liabilities | 13.358 | 5.385 | 8.409 | 8.771 | 7.859 |
Accounts Payable | 2.211 | 1.916 | 3.124 | 3.994 | 3.721 |
Payable/Accrued | 5.231 | 2.119 | 2.972 | 2.494 | 2.869 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0.798 | 0.31 | 1.477 | 1.229 | 1.243 |
Other Current Liabilities, Total | 5.118 | 1.04 | 0.836 | 1.054 | 0.026 |
Total Liabilities | 17.518 | 5.385 | 19.7 | 19.892 | 18.742 |
Total Long Term Debt | 4.16 | 0 | 11.291 | 11.121 | 10.883 |
Capital Lease Obligations | 4.16 | 0 | 11.291 | 11.121 | 10.883 |
Total Equity | 100.79 | 91.182 | 97.412 | 84.43 | 87.016 |
Common Stock | 204.652 | 241.537 | 295.909 | 296.524 | 307.606 |
Retained Earnings (Accumulated Deficit) | -148.104 | -163.729 | -198.497 | -212.094 | -220.59 |
Other Equity, Total | 44.242 | 13.374 | 0 | 0 | |
Total Liabilities & Shareholders’ Equity | 118.308 | 96.567 | 117.112 | 104.322 | 105.758 |
Total Common Shares Outstanding | 1067.15 | 1069.13 | 1153.42 | 1154.06 | 1167.93 |
- Letni
- Četrtletno
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Čisti prihodki/začetna postavka | -16.046 | -20.197 | -18.735 | -22.24 | -22.021 | -90.076 |
Denarna sredstva iz poslovanja | -9.625 | -11.823 | -13.427 | -13.113 | -15.746 | -39.839 |
Denarna sredstva iz poslovanja | 0.41 | 0.163 | 0.197 | 1.077 | 1.067 | 1.476 |
Nedenarne postavke | 3.277 | 7.76 | 3.143 | 5.673 | 4.89 | 57.174 |
Spremembe v obratnem kapitalu | 2.734 | 0.451 | 1.968 | 2.377 | 0.318 | -8.413 |
Denarna sredstva pri naložbenju | -0.18 | -0.269 | -0.341 | -0.187 | -0.254 | -6.176 |
Kapitalski izdatki | -0.191 | -0.269 | -0.341 | -0.187 | -0.254 | -5.809 |
Celotne druge postavke denarnih tokov pri naložbenju | 0.011 | 0 | 0 | -0.367 | ||
Denarna sredstva pri financiranju | 6.795 | 13.416 | 19.559 | 4.918 | 31.921 | 113.418 |
Postavke denarnega toka pri financiranju | 0.731 | 0 | 16.424 | 5.435 | 0 | 0 |
Izdaja (odplačilo) delnic, neto | 1.546 | 0.92 | 0.909 | 0.146 | 0.132 | 18.216 |
Izdaja (odplačilo) dolga, neto | 4.518 | 12.496 | 2.226 | -0.663 | 31.789 | 95.202 |
Neto sprememba denarnih sredstev | -3.01 | 1.324 | 5.916 | -8.536 | 15.981 | 63.464 |
Učinki deviznih tečajev | 0.125 | -0.154 | 0.06 | -3.939 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -44.958 | -62.541 | -74.069 | -90.076 | -7.304 |
Cash From Operating Activities | -19.798 | -28.644 | -33.442 | -39.839 | -8.254 |
Cash From Operating Activities | 0.281 | 0.402 | 0.905 | 1.476 | 0.542 |
Non-Cash Items | 32.52 | 44.179 | 48.25 | 57.174 | -0.171 |
Changes in Working Capital | -7.641 | -10.684 | -8.528 | -8.413 | -1.321 |
Cash From Investing Activities | -0.445 | -1.237 | -3.391 | -6.176 | -4.075 |
Capital Expenditures | -0.445 | -0.87 | -3.024 | -5.809 | -4.075 |
Cash From Financing Activities | 91.829 | 95.613 | 113.478 | 113.418 | 2.816 |
Financing Cash Flow Items | 45.942 | 13.374 | 0 | 0 | 0 |
Issuance (Retirement) of Stock, Net | 2.712 | 2.879 | 17.765 | 18.216 | 3.058 |
Issuance (Retirement) of Debt, Net | 43.175 | 79.36 | 95.713 | 95.202 | -0.242 |
Foreign Exchange Effects | 1.106 | -0.561 | -1.264 | -3.939 | 1.913 |
Net Change in Cash | 72.692 | 65.171 | 75.381 | 63.464 | -7.6 |
Other Investing Cash Flow Items, Total | -0.367 | -0.367 | -0.367 | 0 |
Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
---|---|---|---|---|---|---|
Meretzki (Shai) | Individual Investor | 32.966 | 385017966 | 5551455 | 2022-12-28 | |
Rauch (Yosef) | Individual Investor | 11.383 | 132945004 | 875000 | 2022-12-28 | |
Shapira (Gil) | Individual Investor | 0.6085 | 7106418 | 0 | 2022-12-28 | |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.1 | 1167456 | 19019 | 2023-02-28 | LOW |
Reznick (Yehuda) | Individual Investor | 0.0626 | 730797 | 0 | 2022-12-28 |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com GroupBorzni posredniki
Aktivne stranke mesečno
Mesečni obseg naložb
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Bonus BioGroup Ltd. Company profile
O družbi Bonus BioGroup Ltd.
Bonus Biogroup Ltd, prej Oceana Advanced Industries Ltd, je biotehnološko podjetje s sedežem v Izraelu, ki se osredotoča na izdelke in uporablja tehnologijo za dobavo tkiv za obnovo kosti. Družba razvija izdelke celične terapije na podlagi avtolognih in alogeničnih kostnih vsadkov, ki bodo omogočili učinkovito presaditev kosti in zagotovili protetiko za nadomestitev kosti na celični osnovi za popravljanje kostnih poškodb. Usmerjeno je na svetovni trg za zdravljenje večjih motenj, kot so artritis, povezan s kostmi in hrustancem, osteoporoza ter različne vrste poškodb kosti in sklepov, kot so med drugim zlomi kolka in poškodbe kolena. Družba Bonus Bio Group Ltd. je 29. aprila 2012 v celoti prevzela družbo Bonus Therapeutic Ltd.
Industry: | Bio Medical Devices |
פארק מת"מ 8ב'
HAIFA
3190501
IL
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 500.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com